Article
Enhancement of FK506 production by engineering secondary pathways of <i>Streptomyces tsukubaensis</i> and exogenous feeding strategies
18 Jun 2013
Abstract excerpt
FK506 is a clinically important macrocyclic polyketide with immunosuppressive activity produced by Streptomyces tsukubaensis. However, the low titer at which it is produced is a bottleneck to its application and use in industrial processes. We have overexpressed five potential targets associated with FK506 production (fkbO, fkbL, fkbP, fkbM, fkbD) which were identified in our previous study, with the aim to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
